What is Alamar Biosciences, Inc.'s (ALMR) StockRank?

MoatMap's StockRank for Alamar Biosciences, Inc. (ALMR) is 20/100, with a Sell signal. This is a composite score combining Quality (41), Value (23), and Momentum (41) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Alamar Biosciences, Inc. have an economic moat?

Alamar Biosciences, Inc. (ALMR) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Alamar Biosciences, Inc. a buy, hold, or sell?

MoatMap's current signal for Alamar Biosciences, Inc. (ALMR) is Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Alamar Biosciences, Inc. in?

Alamar Biosciences, Inc. (ALMR) operates in the Healthcare sector, specifically the Medical Devices industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

ALMR

SellSinker

Alamar Biosciences, Inc. · Healthcare · United States · $2.1B · Avg Vol: $9M/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

—

D/E

0.2x

Dividend %

—

COMPANY DESCRIPTION

Alamar Biosciences, Inc. is a life sciences company developing advanced proteomics technologies designed for the early detection and treatment of cancer and inflammatory diseases. The company's proprietary NULISA and Attobody platforms enable ultra-high sensitivity protein detection, overcoming limitations of traditional assays. Its competitive moat is anchored by its cutting-edge molecular detection technology and its potential to revolutionize liquid biopsy and biomarker research.

FINANCIAL SUMMARY (USD)

Year	2024	2025	TTM	2026E	2027E	Fwd CAGR
Revenue	25.1M	74.2M	100.4M	118.6M	165.7M	49.4%
EPS	-0.71	-0.45	-0.72	-1.16	-0.54	—
Shares	66.5M	66.5M	69.4M	—	—	—
Debt	33.1M	41.5M	51.4M	—	—	—
Equity	-133.4M	-159.0M	—	—	—	—
Op CF	-55.2M	-53.6M	-60.3M	—	—	—
Inv CF	-53.9M	46.2M	—	—	—	—
Fin CF	113.4M	10.8M	—	—	—	—

Loading 1Y...

PRICE (1Y)+18.8%

SMA 50SMA 200

$28.96

RSI (14)

23.1

SCORE BREAKDOWN

Quality

ROIC

-24.7%27.3

ROE

—N/A

GP/Assets

42.1%80.4

Op. Margin

-46.0%20.9

FCF/Assets

-39.0%9.3

Piotroski

549.3

Int. Cover

-50.0x5.9

D/E Ratio

0.16x53.9

Current Ratio

11.85x89.9

Value

P/E (TTM)

—N/A

EV/EBITDA

-51.7x25.0

P/FCF

—N/A

P/B

6.8x19.6

P/S

21.3x15.5

Div Yield

—N/A

Momentum

52W High %

—N/A

RS 6M

—N/A

SMA 50/200

—N/A

EPS Rev 4W

+22.9%95.3

EPS Rev 12W

+22.9%92.2

EPS Improve

+25%37.9

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$2.1B

P/E (Forward)

-56.8x

Gross Margin

58.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ALMR are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
ALMR	Alamar Biosciences, Inc.(you)	$2.1B	20	Sell
ESTA	Establishment Labs Holdings Inc.	$2.1B	23	Sell
ATEC	Alphatec Holdings, Inc.	$1.5B	27	Sell
TMDX	TransMedics Group, Inc.	$3.1B	28	Sell
PRCT	PROCEPT BioRobotics Corporation	$1.2B	15	Strong Sell
TNDM	Tandem Diabetes Care, Inc.	$1.5B	31	Sell
LMRI	Lumexa Imaging Holdings, Inc.	$1.1B	28	Sell
BFLY	Butterfly Network, Inc.	$2.2B	41	Hold
CBLL	CeriBell, Inc.	$911M	27	Sell
QDEL	QuidelOrtho Corporation	$1.0B	29	Sell

Peer medians: ROE -30.7% · P/E 27.0x · Gross margin 58.1%

Alamar Biosciences, Inc. (ALMR): Stock Score Summary

Alamar Biosciences, Inc. (ALMR) has a MoatMap StockRank of 20/100 based on Quality (41/100), Value (23/100), and Momentum (41/100) factor scores. The current signal is SELL.

Key Financial Metrics

Price	$28.96
Market Cap	$2.1B
P/E (Forward)	-56.78
Price/Book	6.83
Return on Invested Capital	-24.7%
Debt/Equity	0.16x
Gross Margin	58.7%
Operating Margin	-46.0%
Revenue Growth	82.1%
Free Cash Flow	$-55M

Alamar Biosciences, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Alamar Biosciences, Inc.’s (ALMR) StockRank?: MoatMap’s StockRank for Alamar Biosciences, Inc. (ALMR) is 20/100, with a Sell signal. It is a composite of Quality (41), Value (23), and Momentum (41) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Alamar Biosciences, Inc. have an economic moat?: Alamar Biosciences, Inc. (ALMR) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Alamar Biosciences, Inc. a buy, hold, or sell?: MoatMap’s current signal for Alamar Biosciences, Inc. (ALMR) is Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Alamar Biosciences, Inc. in?: Alamar Biosciences, Inc. (ALMR) operates in the Healthcare sector, specifically the Medical Devices industry (United States).